FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug - Reuters
FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMizwFBVV95cUxOb2M0aXZtM3RvVDBpVnc2V3I2ZXpWc2Q3aVJzY3R5OWw3M0NlOEN4cGExc1liYmh4Mkt6TzBrRjh6YTlVT0tFbzk5aFZnRTAxcUxhSWplX0E2aVdBRWt0bVdJNzR4WGFtM2c2Vi1ZdC13R21qOXFNSkVXeXJnaE9FQTFya2pOY0hCZ3dGVXZfQXZHTUxHSG5YaHBpWkxEUjVQdzhJcUxGeFJyRGhwRGtTTXlVcmxvaGZ0bUR2S3NxYlUxNTZCMG5CNzhPY3YzWTQ?oc=5" target="_blank">FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
US FDA approves Vera's kidney disease drug - Reuters
US FDA approves Vera's kidney disease drug Reuters
July 7, 2026 at 05:09 PMUS FDA approves Sanofi's wearable injector form of blood cancer drug - Reuters
US FDA approves Sanofi's wearable injector form of blood cancer drug Reuters
July 10, 2026 at 05:49 PMAstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports - Reuters
AstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports Reuters
July 8, 2026 at 06:34 PMOxford begins first human trial of Bundibugyo Ebola vaccine - Reuters
Oxford begins first human trial of Bundibugyo Ebola vaccine Reuters
July 13, 2026 at 09:47 AMGSK, Hansoh's targeted cancer drug hits main survival goal in China trial - Reuters
GSK, Hansoh's targeted cancer drug hits main survival goal in China trial Reuters
July 10, 2026 at 01:46 PMSouth African regulators issue recall of Ozempic copies - Reuters
South African regulators issue recall of Ozempic copies Reuters
July 9, 2026 at 09:14 PM